126 related articles for article (PubMed ID: 20724921)
1. The ocular surface in thyroid diseases.
Versura P; Campos EC
Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):486-92. PubMed ID: 20724921
[TBL] [Abstract][Full Text] [Related]
2. Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?
Gopinath B; Wescombe L; Nguyen B; Wall JR
Orbit; 2009; 28(4):256-61. PubMed ID: 19839885
[TBL] [Abstract][Full Text] [Related]
3. Ocular surface and dry eye in Graves' disease.
Gürdal C; Saraç O; Genç I; Kırımlıoğlu H; Takmaz T; Can I
Curr Eye Res; 2011 Jan; 36(1):8-13. PubMed ID: 21174592
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of Graves' ophthalmopathy.
Stiebel-Kalish H; Robenshtok E; Gaton DD
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():178-81. PubMed ID: 20467359
[TBL] [Abstract][Full Text] [Related]
7. Some immunological correlations between thyroid pathology and ophthalmopathy.
Kandror V; Birjukova M; Kryukova I; Mkrtumova N; Konnova E
Exp Clin Endocrinol; 1991 May; 97(2-3):212-6. PubMed ID: 1915637
[TBL] [Abstract][Full Text] [Related]
8. Strabismus associated with thyroid eye disease.
Schotthoefer EO; Wallace DK
Curr Opin Ophthalmol; 2007 Sep; 18(5):361-5. PubMed ID: 17700227
[TBL] [Abstract][Full Text] [Related]
9. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
[TBL] [Abstract][Full Text] [Related]
10. [The role of antibodies in Graves' ophthalmopathy].
Molnár I; Balázs C
Orv Hetil; 1991 Sep; 132(38):2097-100. PubMed ID: 1923482
[TBL] [Abstract][Full Text] [Related]
11. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
Ohkura T; Taniguchi S; Yamada K; Nishio N; Okamura T; Yoshida A; Kamijou K; Fukata S; Kuma K; Inoue Y; Hisatome I; Senju S; Nishimura Y; Shigemasa C
Biochem Biophys Res Commun; 2004 Aug; 321(2):432-40. PubMed ID: 15358194
[TBL] [Abstract][Full Text] [Related]
12. Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy.
Parmar H; Ibrahim M
Neuroimaging Clin N Am; 2008 Aug; 18(3):527-36, viii-ix. PubMed ID: 18656033
[TBL] [Abstract][Full Text] [Related]
13. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
14. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy.
Salvi M; Miller A; Wall JR
FEBS Lett; 1988 May; 232(1):135-9. PubMed ID: 3366241
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy.
Eckstein A; Esser J; Mann K; Schott M
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():198-203. PubMed ID: 20467363
[TBL] [Abstract][Full Text] [Related]
16. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
17. Graves' ophthalmopathy.
Bahn RS
N Engl J Med; 2010 Feb; 362(8):726-38. PubMed ID: 20181974
[TBL] [Abstract][Full Text] [Related]
18. Endocrine ophthalmopathy and radioiodine therapy.
Karlsson FA
Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
[TBL] [Abstract][Full Text] [Related]
19. [Endocrine orbitopathy and significance of autoantibodies against 1D protein].
Hrdá P; Sterzl I; Vána S; Novák Z; Matucha P; Kromminga A
Cas Lek Cesk; 2007; 146(3):273-7. PubMed ID: 17419313
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity against eye-muscle antigens may explain thyroid-associated ophthalmopathy.
Tani J; Wall JR
CMAJ; 2006 Aug; 175(3):239. PubMed ID: 16880438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
